fisons strong international growth fisons plc fisnl strong international growth main feature progress pharmaceutical division report pct increase sale period rise due sustain market programme larger sale force introduction aerosol form intal antiasthma drug push sale pct company comment result pretax profit rise million stg million result line market forecast share nevertheless ease fall market gmt fisons potential future growth intral opticrom nasalcrom product indicate strong performance scientific equipment business raise proportion technology product manufacture raise ability generate margin horticulture operation demonstrate outstanding market ability underlie cash flow operation positive despite programme capital investment action protect foreign currency movement result net profit 
